Abstract
Solitary metachronous small bowel metastasis from renal cell carcinoma (RCC) is an exceptionally rare clinical event. While intussusception is a common cause of bowel obstruction in children, in adults it almost always indicates an underlying malignancy acting as a "lead point." We present the case of an 84-year-old male who developed small bowel intussusception due to a solitary RCC metastasis five years after his initial nephrectomy. This case highlights the "chameleon-like" nature of RCC, which can remain dormant for decades before recurring in atypical sites.
Introduction
Renal cell carcinoma (RCC) is notorious for its unpredictable metastatic behavior. While it commonly spreads to the lungs, bones, and liver, metastasis to the small bowel occurs in only about 1.1% of cases. Metachronous metastasis—defined as a recurrence occurring at least six months after the primary tumor removal—can manifest years or even decades later. In adults, intussusception is a surgical emergency that requires identifying the pathological lead point, which is frequently a metastatic lesion in patients with a history of malignancy.
Case Presentation
An 84-year-old man presented with acute symptoms of small bowel obstruction, including intermittent abdominal pain, distention, and cessation of bowel movements. His medical history was significant for a radical nephrectomy performed for clear cell RCC (ccRCC) five years prior.
Diagnostic Imaging
Contrast-enhanced Computed Tomography (CT) was performed to investigate the cause of the obstruction. The imaging revealed a 4 × 4 cm intraluminal soft-tissue mass with moderate enhancement in the distal ileum, which was identified as the lead point for the intussusception.
Surgical Management and Pathology
The patient underwent an urgent exploratory laparotomy. Surgeons identified a pedunculated tumor in the distal ileum that had served as the lead point. A reduction of the intestinal invagination and a segmental resection of the ileum with functional end-to-end anastomosis were performed.
Postoperative histological examination and immunohistochemistry (IHC) confirmed the diagnosis. The tumor cells expressed markers characteristic of renal origin, including PAX-8, CD10, and CAIX. The patient’s recovery was uneventful, and he was discharged on postoperative day six.
Literature Review and Discussion
A systematic review of literature spanning 1952 to 2022 was conducted to contextualize this rare occurrence. The search identified 21 cases meeting the strict criteria for solitary metachronous small bowel metastasis from RCC.
Key Insights
- The Danger of Dormancy: The review found that RCC metastases can appear between 8 months and 20 years after the initial surgery. This suggests that the standard five-year follow-up may be insufficient for RCC patients, who may require lifelong vigilance.
- Atypical Metastatic Pathways: Traditional models suggest RCC spreads first to the lungs via the renal vein. However, this case and others in the cohort show isolated small bowel involvement without pulmonary disease, challenging established understandings of RCC progression.
- Clinical Presentation: While intussusception is an acute presentation, more common symptoms in the literature cohort included gastrointestinal bleeding, melena, and iron deficiency anemia.
Conclusion
This case underscores the rarity of solitary metachronous small bowel metastases from RCC and the unpredictable nature of the disease. Complete surgical resection remains the mainstay of treatment, offering favorable local control. Given the potential for long-term dormancy, clinicians should consider lifelong follow-up for RCC patients to detect late-stage recurrences early.
Summary updated